1. Introduction {#s0095}
===============

[l]{.smallcaps}-Proline plays many important roles in the protein structure and cell signaling and is synthesized within cells and organisms from an intermediate, glutamate γ-semialdehyde, commonly involved in biosynthesis pathways from [l]{.smallcaps}-glutamate and [l]{.smallcaps}-arginine: [l]{.smallcaps}-glutamate → γ-glutamyl phosphate → glutamate γ-semialdehyde (Route 1); [l]{.smallcaps}-arginine → [l]{.smallcaps}-ornithine → glutamate γ-semialdehyde (Route 2) ([Fig. 1](#f0005){ref-type="fig"}A). The glutamate γ-semialdehyde then undergoes "non-enzymatic cyclization" to give the imine, Δ^1^-pyrroline-5-carboxyrate (Pyr5C), which is subsequently converted to [l]{.smallcaps}-proline by NAD(P)H-dependent Pyr5C reductase (EC 1.5.1.2) [@b0005]. Route 1 is the main mechanism of [l]{.smallcaps}-proline biosynthesis in bacteria, while eukaryotes use this route predominantly under stress and limited nitrogen conditions. Under high nitrogen input, Route 2 appears to be prominent and is mainly found in higher plants.

Alternatively, [l]{.smallcaps}-proline is also directly synthesized from the amino acid [l]{.smallcaps}-ornithine, itself an intermediate along the above Route 2, by [l]{.smallcaps}-ornithine cyclodeaminase (OCD; EC 4.3.1.12) (Route 3) [@b0010]. This unique enzyme initially catalyzes NAD^+^-dependent oxidative deamination from the α-amino group of [l]{.smallcaps}-ornithine, and subsequently cyclization to form Δ^1^-pyrroline-2-carboxyrate (Pyr2C) ([Fig. 1](#f0005){ref-type="fig"}B). The actual cyclization step in this pathway occurs with the participation of enzymes, in contrast to glutamate γ-semialdehyde → Pyr5C in Routes 1 and 2, described above. The final step by OCD is NADH-dependent reduction of Pyr2C to [l]{.smallcaps}-proline. OCD belongs to the ornithine cyclodeaminase/μ-crystallin (OCD/CRYM) superfamily (see [Fig. 4](#f0020){ref-type="fig"}). It was recently reported that μ-crystallin (CRYM) from mammalians, known as an NADPH-dependent T3 thyroid hormone (triiodothyronin)-binding protein without enzymatic catalysis, functions as an NAD(P)H-dependent ketimine reductase (EC 1.5.1.25) [@b0015]. Pyr2C is one of the substrates of this enzyme.

Although Route 3 of [l]{.smallcaps}-proline biosynthesis is found in several bacteria, including *Pseudomonas putida* [@b0010], *Agrobacterium tumefaciens* [@b0020], *Clostridium sporogenes* [@b0025], and *Sinorhizobium meliloti* [@b0030], many archaea possess OCD/CRYM family genes (proteins) (20--40% sequence identity with bacterial OCD). Among them, only AF1665 protein (gene) from the hyperthermophilic archaeon *Archaeoglobus fulgidus* has been characterized at the molecular level, and the protein functions as an [l]{.smallcaps}-alanine dehydrogenase (AlaDH; EC 1.4.1.1) but not OCD: [l]{.smallcaps}-alanine + NAD^+^ + H~2~O ↔ pyruvate + NH~3~ + NADH + H^+^ [@b0035; @b0040]. It is proposed that the enzyme (AfAlaDH) is involved in [l]{.smallcaps}-alanine metabolism (degradation), whereas the catalytic efficiency value for pyruvate is much higher than that for [l]{.smallcaps}-alanine. Although OCD activity is detected in a cell-free extract of *Methanococcus jannaschii* [@b0045], no OCD/CRYM family gene is found on the genome. Up to now, the physiological role of OCD-like protein including AfAlaDH has been unclear in archaea.

There are two different mechanisms for OCD ([Fig. 1](#f0005){ref-type="fig"}B), in which [l]{.smallcaps}-ornithine is initially oxidized to an iminium (C~α~ = NH~2~^+^ containing) intermediate (step 1 in [Fig. 1](#f0005){ref-type="fig"}B). In scheme I, the iminium undergoes hydrolysis to 2-oxo-5-aminovalerate by water before cyclization (step 2), and elimination of water produces Pyr2C (step 3). This scheme is analogous to the oxidative deamination of [l]{.smallcaps}-amino acid to 2-oxo acids by AlaDH [@b0040], and has been preliminarily proposed based on biochemical experiments [@b0050]. However, the crystal structure and molecular dynamic analysis of OCD [@b0010; @b0055] indicate an alternative mechanism (scheme II) that no attack on the iminium by water occurs: intramolecular cyclic addition of C-5 nitrogen of the iminium to the C-2 carbon to form 2-aminoproline (step 4), loss of ammonia, and reduction of the resulting imine, Pyr2C (step 5).

Recently, we characterized novel bacterial pathways of *trans*-4-hydroxy-[l]{.smallcaps}-proline (T4LHyp) and *trans*-3-hydroxy-[l]{.smallcaps}-proline (T3LHyp) metabolism [@b0060; @b0065]. In mammalian systems, T4LHyp and T3LHyp occur by post-translational hydroxylation of [l]{.smallcaps}-proline residue in certain proteins, in particular, collagen [@b0070]. In contrast to T4LHyp, the metabolic pathways of T3LHyp from bacteria and mammalians may be similar [@b0065; @b0075] and consist of two enzymes, T3LHyp dehydratase (encoded by *LhpH* gene; EC 4.2.1.77) and NAD(P)H-dependent Pyr2C reductase (encoded by *LhpI* gene; EC 1.5.1.1), by which T3LHyp is converted to [l]{.smallcaps}-proline via Pyr2C ([Fig. 1](#f0005){ref-type="fig"}C). Interestingly, LhpI protein is a novel member of the OCD/CRYM superfamily, and catalyzes only the reduction of Pyr2C to [l]{.smallcaps}-proline (no OCD activity) [@b0055]. Furthermore, there is no sequence similarity to DpkA protein as is known for the reductase of Pyr2C from bacteria [@b0080], strongly suggesting their convergent evolution.

Metabolism of T3LHyp (and T4LHyp) by archaea has been unclear until now, and it is impossible to further assess the physiological functions of OCD-like proteins in archaea based on a simple homology search. In this study, we selected OCD-like protein (gene) from a hyperthermophilic archaeon, *Thermococcus litoralis* DSM 5473, as a target, and this protein functions as an NAD(P)H-dependent Pyr2C reductase rather than AlaDH. This gene was clustered with T3LHyp dehydratase and proline racemase genes involved in putative T3LHyp and/or proline metabolism. Molecular evolution of the OCD/CRYM family is also discussed.

2. Results {#s0100}
==========

2.1. Candidates of target genes {#s0005}
-------------------------------

Although it is unclear whether there are archaea capable of metabolizing T3LHyp as a sole carbon source, a homology search by the Protein-BLAST program was carried out against genome sequences of archaea using bacterial Pyr2C reductases (LhpI from *Azospirillum brasilense* (AbLhpI), GenBank: [BAO21622](ncbi-p:BAO21622){#ir0005}; LhpI from *Colwellia psychreryth*raea 34H (CpLhpI), GenBank: [YP_268197](ncbi-p:YP_268197){#ir0025}) as the probe protein sequences. As described below, bacterial Pyr2C reductases are classified into two different subfamilies, in which CpLhpI and AbLhpI are contained, respectively (see [Fig. 4](#f0020){ref-type="fig"}). However, over 900 homologous genes (proteins) with sequence identities of 20--40% were found (data not shown). Similar results was also obtained when other OCD/CRYM family proteins including AfAlaDH was used instead of LhpI protein as the probe.

On the other hand, when bacterial T3LHyp dehydratases (LhpH from *A. brasilense* (AbLhpH), GenBank: [BAO21621](ncbi-p:BAO21621){#ir0010}; LhpH from *C. psychrerythraea* 34H (CpLhpH), GenBank: [YP_268195](ncbi-p:YP_268195){#ir0030}) was used as the probe, 31 homologous genes were found. T3LHyp dehydratase belongs to the proline racemase superfamily, which also includes the archetypical proline racemase (EC 5.1.1.4) and T4LHyp epimerase (EC 5.1.1.8) ([Fig. S1](#s0115){ref-type="sec"}) [@b0075; @b0085]. In contrast to bacterial Pyr2C reductases, T3LHyp dehydratase form a single subclass in this superfamily. On the basis of two specific residues at the active sites, the members have been classified into three types: Cys-Cys type (proline racemase and T4LHyp epimerase); Cys-Thr type (T3LHyp dehydratase); Ser-Cys type (function unknown). Furthermore, two Cys-Cys type enzymes can be clearly distinguished in the phylogenetic tree. Based on this insight, we could select only three proline racemase-like genes as putative T3LHyp dehydratases, although it has been believed that the enzyme is found only in animals and fungi (and bacteria) [@b0065; @b0075]: *T. litoralis* DSM 5473 (OCC_00387, GenBank: [YP_008428263](ncbi-p:YP_008428263){#ir0035}; 45.6% identity with AbLhpH), *Thermococcus sibiricus* MM 739 (TSIB_0630, GenBank: [YP_002994044](ncbi-p:YP_002994044){#ir0040}; 47.1%), and *Candidatus Korarchaeum cryptofilum* OPF8 (OPF8 Kcr_0803, GenBank: [YP_001737233](ncbi-p:YP_001737233){#ir0065}; 44.1%) ([Fig. 1](#f0005){ref-type="fig"}). Interestingly, these genes were clustered with OCD-like genes: *T. litoralis* (OCC_00362→[YP_008428257](ncbi-p:YP_008428257){#ir0045} OCC_00367, GenBank: [YP_008428258](ncbi-p:YP_008428258){#ir0050}); *T. sibiricus* (TSIB_0634, GenBank: [YP_002994048](ncbi-p:YP_002994048){#ir0055}); *K. cryptofilum* (Kcr_0796, GenBank: [YP_001737226](ncbi-p:YP_001737226){#ir0060}) ([Fig. 1](#f0005){ref-type="fig"}D). In the cases of *T. litoralis* and *T. sibiricus*, another proline racemase-like gene (Cys-Cys type) and genes encoding two different types of putative heterooligomeric [l]{.smallcaps}-proline dehydrogenase ([l]{.smallcaps}-ProDH) [@b0090; @b0095] were also contained in this gene cluster. This analysis strongly indicated that the gene cluster is related to T3LHyp and/or proline metabolism. Therefore, in this study, we selected GenBank: OCC_00362, GenBank: OCC_00367, and GenBank: OCC_00387 genes from *T. litoralis* as target genes (referred to as *TlLhpI* and *TlLhpH* genes, respectively).

2.2. Preparation of recombinant His~6~-tag proteins {#s0010}
---------------------------------------------------

*TlLhpI* gene was fused with OCC_00362 and OCC_00367 genes by PCR ([Supplementary Methods](#s0115){ref-type="sec"}). After cloning all target genes into the vector pETDuet-1, the recombinant enzymes with attached His~6~-tags at their N-termini were expressed in *Escherichia coli* and purified with an Ni^2+^-chelating affinity column ([Fig. 1](#f0005){ref-type="fig"}E). Apparent molecular masses of TlLhpI and TlLhpH, estimated by SDS--PAGE, were 40 (36.9) and 43 (38.1) kDa (values in parentheses indicate the calculated molecular mass of the enzyme with His~6~-tag), and those estimated by analytic gel filtration were 72 and 75 kDa, respectively (data not shown). Therefore, the two enzymes appear to be dimeric.

2.3. Characterization of TlLhpI as AlaDH {#s0015}
----------------------------------------

Although TlLhpI shows only 44.3% sequence identity with AfAlaDH, we could detect both activities of the NAD^+^-dependent oxidative deamination of [l]{.smallcaps}-alanine and NADH-dependent reductive amination of pyruvate (in presence of 700 mM NH~4~^+^): specific activities of 0.0265 and 4.43 (unit/mg protein), respectively. NADP^+^ was not used as a coenzyme. The optimum pH values of each reaction were 10--12 and 6--10.5, respectively ([Fig. 2](#f0010){ref-type="fig"}A). The *k*~cat~/*K*~m~ value for pyruvate was ∼230-fold higher than that for [l]{.smallcaps}-alanine, caused by the ∼120-fold lower *K*~m~ value: namely, the reaction equilibrium favors the direction toward reductive amination ([Tables 1 and 2](#t0005 t0010){ref-type="table"}). Activity was also observed with several [l]{.smallcaps}-amino acids and 2-oxo acids with a hydrophobic side chain (see below for [l]{.smallcaps}-proline). Among them, [l]{.smallcaps}-2-aminovalerate and 2-oxovalerate with a C~3~ aliphatic side chain were the best substrates, and the *k*~cat~/*K*~m~ values were 146- and 4.7-fold higher than those for [l]{.smallcaps}-alanine and pyruvate, respectively. When pyruvate and NADH were alternatively incubated together with methylamine (50 mM) instead of NH~4~^+^ as the nitrogen donor, reduction activity was detected. This result indicated that TlLhpI functions not only as AlaDH but also *N*-methyl-[l]{.smallcaps}-alanine dehydrogenase (NMAlaDH; EC 1.4.1.17). Activities of AlaDH and NMAlaDH were also detected in HPLC analysis using the reaction products and zymogram staining analysis (Figs. [2](#f0010){ref-type="fig"}B and [3](#f0015){ref-type="fig"}A, B).*k*~cat~/*K*~m~ values for [l]{.smallcaps}-alanine and pyruvate of TlLhpI were over 1000-fold lower than those of AfAlaDH [@b0035]. Furthermore, the *K*~m~ value for NH~4~^+^ of TlLhpI was clearly beyond the physiological level ([Table 2](#t0010){ref-type="table"}). AfAlaDH shows similar optimum pH of the oxidative and reductive reactions (∼7.0), and no significant activity for hydrophobic amino acids including [l]{.smallcaps}-2-aminovalerate (2-oxovalerate). This indicated strongly that TlLhpI possesses largely different properties from AfAlaDH, and that the physiological function is not the metabolism of [l]{.smallcaps}-alanine and pyruvate.

2.4. Characterization of TlLhpI as novel Pyr2C reductase in OCD/CRYM superfamily {#s0020}
--------------------------------------------------------------------------------

In contrast to AfAlaDH [@b0035], TlLhpI showed NAD^+^-dependent oxidization activity for [l]{.smallcaps}-proline. The *k*~cat~/*K*~m~ value in the presence of NADP^+^ was ∼50-fold lower than that in the presence of NAD^+^ ([Table 1](#t0005){ref-type="table"}): the specificity for NAD^+^ is described above. In addition to [l]{.smallcaps}-proline, several [l]{.smallcaps}-proline analogs, including *cis*-4-hydroxy-[l]{.smallcaps}-proline (85%), *trans*-4-hydroxy-[l]{.smallcaps}-proline (70%), and [l]{.smallcaps}-pipecolate (49%), were active substrates (relative activity to [l]{.smallcaps}-proline in parentheses), whereas it is known that bacterial LhpI proteins are strictly specific to [l]{.smallcaps}-proline [@b0065]. These activities were also detected in zymogram staining analysis ([Fig. 2](#f0010){ref-type="fig"}B). When the reaction product of [l]{.smallcaps}-proline was further oxidized by H~2~O~2~, 4-aminobutyrate (GABA) was identified in HPLC analysis ([Fig. 3](#f0015){ref-type="fig"}C), indicating that TlLhpI catalyzes the conversion of [l]{.smallcaps}-proline to Pyr2C. Generally, [l]{.smallcaps}-ProDH (EC 1.5.99.8) including archaeal enzymes [@b0090; @b0095] is a flavoprotein, and the reaction product is Pyr5C (if so, [l]{.smallcaps}-glutamate is yielded by the above H~2~O~2~ treatment).

Therefore, we compared the dehydrogenation activity toward [l]{.smallcaps}-proline and other [l]{.smallcaps}-amino acids ([Tables 1 and 2](#t0005 t0010){ref-type="table"}). The *k*~cat~/*K*~m~ value for Pyr2C (1058 min^−1^ mM^−1^) was 6.7-fold higher than that for 2-oxovalerate, caused by the high *k*~cat~ value. Furthermore, the ratio of Pyr2C to [l]{.smallcaps}-proline in *k*~cat~/*K*~m~ was 86, suggesting the preference of the reaction equilibrium in the direction toward NADH-dependent reduction. Interestingly, the optimum pH of Pyr2C reductase was 4.0--6.0, clearly different from that of the reductive deamination of AlaDH (pH 6--10.5) ([Fig. 2](#f0010){ref-type="fig"}A). These results strongly indicated that Pyr2C is the preferred substrate for TlLhpI. Although AbLhpI and CpLhpI showed only 25.3% and 31.6% sequence identity to TlLhpI, respectively, we unexpectedly detected AlaDH activity in both enzymes ([Fig. 3](#f0015){ref-type="fig"}C). Commonly, these bacterial enzymes showed significantly high ratios of Pyr2C to pyruvate in specific activity: 176 and 28, respectively (∼5 for TlLhpI). Namely, TlLhpI possessed "vestigial" properties to AlaDH, probably due to the close phylogenetic relationship between them, as described in the main section.

Using the reductase activity toward Pyr2C, several properties of TlLhpI as an enzyme from "hyperthermophiles" were identified: *T. litoralis* grows between 55 and 98 °C with an optimal growth temperature of 88 °C [@b0100]. Although the optimum temperature was above 75 °C, and clearly higher than that of (mesophilic) AbLhpI, the assay could not be performed above 75 °C due to the thermolability of NADH ([Fig. S2A](#s0115){ref-type="sec"}). Thus, TlLhpI appears to be a typical (hyper)thermophilic enzyme.

2.5. Phylogenetic analysis of TlLhpI {#s0025}
------------------------------------

As expected from the preliminary annotation, TlLhpI belongs to the OCD/CRYM superfamily, including the archetype OCD (subfamilies 7 and 11) [@b0010; @b0105], CRYM/ketimine reductase (subfamily 5) [@b0015], AlaDH (subfamily 2) [@b0035; @b0040], [l]{.smallcaps}-arginine dehydrogenase (subfamily 10) [@b0110], [l]{.smallcaps}-lysine cyclodeaminase (EC 4.3.1.28; subfamily 8) [@b0115], tauropine and strombine dehydrogenases (EC 1.5.1.23(22); subfamily 3) [@b0120; @b0125], [l]{.smallcaps}-2,3-diaminopropionate synthase (subfamily 4) [@b0130], and Pyr2C reductase (from bacteria) (subfamilies 6 and 9) [@b0065] ([Fig. 4](#f0020){ref-type="fig"}). TlLhpI had a poor relationship to the bacterial LhpI and mammalian CRYM proteins, in spite of their similar activity, and formed a close but distinct subfamily to many archaeal OCD-like proteins, including AfAlaDH (novel subfamily 1). Surprisingly, two OCD-like proteins from "thermophilic bacteria", *Thermosediminibacter oceani* (Toce_0467) and *Thermovirga lienii* (Tlie_1581), were closely related to TlLhpI rather than (bacterial) AbLhpI and CpLhpI, suggesting the possibility of horizontal gene transfer between bacteria and archaea.

Putative amino acid sequences of TlLhpI contained essential amino acid residues for coenzyme binding (Rossmann-fold motif consisting of Gly-*X*-Gly-*X*~2~-\[Ala/Ser\], where X indicates any amino acid) and the catalytic tetrad for interacting (and/or binding) with carboxyl and amino groups of substrate (\[Arg/Lys\]-Lys-Arg-Asp): Gly^134^-Ala-Gly-Val-Gln-Ala^139^ and Arg^39^-Lys^67^-Arg^110^-Asp^303^, respectively [@b0010; @b0040] ([Fig. 5](#f0025){ref-type="fig"}). Furthermore, TlLhpI possessed a specific aspartate residue (Asp^159^) for NAD^+^(H)-dependent enzymes of the OCD/CRYM superfamily [@b0010; @b0035; @b0115; @b0120; @b0125; @b0130], conforming to the coenzyme specificity, described above.

2.6. Identification of catalytic amino acid residues {#s0030}
----------------------------------------------------

It is proposed that three amino acid residues of OCD, E56-D228-K232 (numbering from *P. putida*), are related to the unique cyclization of [l]{.smallcaps}-ornithine [@b0010] ([Fig. 5](#f0025){ref-type="fig"}). In TlLhpI and AfAlaDH, these amino acid residues correspond to L52-V224-A228 and R52-[D219]{.ul}-[K223]{.ul}, respectively (conserved amino acid residues are underlined). To obtain insight into the catalytic mechanism of OCD/CRYM superfamily enzymes, we constructed three mutants of TlLhpI, V224D/A228K (DK mutant), L52E/V224D/A228K (EDK mutant), and L52R/V224D/A228K (RDK mutant). They were overexpressed in *E. coli* cells as a His~6~-tagged enzyme and purified with the same procedures as for the wild-type enzyme ([Fig. 1](#f0005){ref-type="fig"}F). Approximately 12-fold enhancement of Pyr2C reductase activity (6.7-fold for the oxidization activity for [l]{.smallcaps}-proline), but not AlaDH activity, was found in the DK mutant, caused by the increasing *k*~cat~ value ([Tables 1 and 2](#t0005 t0010){ref-type="table"}). On the other hand, when the mutations were combined with L52E and L52R, AlaDH activities for the 2-oxo acids were completely eliminated, whereas Pyr2C reductase activity was the same as in the wild type ([Fig. 2](#f0010){ref-type="fig"}C).

2.7. Characterization of TlLhpH {#s0035}
-------------------------------

Potential T3LHyp dehydratase activity in TlLhpH was initially assayed spectrophotometrically in the coupling system with TlLhpI (in the presence of NADH). A significant decrease in absorbance at 340 nm was observed as a result of cooperative reactions by TlLhpH (T3LHyp → Pyr2C) and TlLhpI (Pyr2C → [l]{.smallcaps}-proline): 44.6 unit/mg protein of specific activity with T3LHyp. *K*~m~ and *k*~cat~ values for T3LHyp were 0.288 mM and 1710 min^−1^, respectively, comparable with those of AbLhpH (data not shown). On the other hand, optimum temperature for the activity was 80--100 °C, which was significantly higher than that of the (mesophilic) AbLhpH (40--45 °C) ([Fig. S2B](#s0115){ref-type="sec"}). These results indicated that the *TlLhpH* gene encodes T3LHyp dehydratase with enzymatic properties as a typical (hyper)thermophilic enzyme: this is the first example for archaea.

2.8. Physiological meaning of TlLhpI and TlLhpH {#s0040}
-----------------------------------------------

Although a minimal medium for the cultivation of *T. litoralis* is not avairable, we found that *T. litoralis* can grow in the complex medium [@b0135] supplemented with [l]{.smallcaps}-proline, [d]{.smallcaps}-proline or T3LHyp as a sole carbon source, instead of maltose and peptone (data not shown). On the other hand, Pyr2C reductase and T3LHyp dehydratase activities in cell-free extract prepared from *T. litoralis* cells grown on such as carbon source were similar to those on maltose and peptone. These suggested one possibility that similar metabolic pathway of T3LHyp to bacteria and mammalian is operative in *T. litoralis*.

3. Discussion {#s0045}
=============

The discovery of archaeal reductase for Pyr2C revealed that OCD/CRYM superfamily enzymes with this activity are large: subfamilies of 1, 5, 6, 7, 9, and 11 at least ([Fig. 4](#f0020){ref-type="fig"}). Furthermore, TlLhpI (and AbLhpI and CpLhpI) possesses not only Pyr2C reductase activity but also (slight but significantly detectable) AlaDH and NMAlaDH activities. Among OCD/CRYM members, enzymatic reactions by subfamilies 2 and 10 are homologous to AlaDH, and enzymes of subfamilies 3 and 4 catalyze similar reactions to NMAlaDH, in which taurine, glycine, and [l]{.smallcaps}-2,3-diaminopropionate are used as the nitrogen donor instead of NH~4~^+^, respectively [@b0120; @b0125; @b0130]. Furthermore, cyclodeaminases for [l]{.smallcaps}-ornithine and [l]{.smallcaps}-lysine possess the same initial step of the catalytic reaction as AlaDH and NMAlaDH (step 1 in [Fig. 1](#f0005){ref-type="fig"}B). This suggests that the origin of [l]{.smallcaps}-ProDH (Pyr2C reductase) activity (step 6) is the same as step 1. A common ancestor possessed NAD(P)^+^-dependent dehydrogenation activity toward broad primary and secondary amines, and (strict) substrate specificity convergently evolved in bacteria, mammalians, and archaea. If this hypothesis is true, TlLhpI acquired catalytic specificity as Pyr2C reductase later than AbLhpI and CpLhpI, because the relative high activity of AlaDH and broad substrate specificity of [l]{.smallcaps}-ProDH remain ([Fig. 2](#f0010){ref-type="fig"}B and C).

Although it is unclear whether OCD possesses (remaining) oxidative deamination activity for [l]{.smallcaps}-amino acid(s) except [l]{.smallcaps}-ornithine, the "potential" mechanism to produce Pyr2C (from [l]{.smallcaps}-ornithine) by TlLhpI corresponds to scheme I, because of the AlaDH activity. Therefore, to obtain evolutional insight into Pyr2C reductase and OCD, we introduced several specific amino acid residues for OCD in TlLhpI by site-directed mutagenesis. Although Asp^228^ of OCD (numbering from *P. putida*) plays an important role in all steps of catalysis [@b0010; @b0055], Asp^219^ conserved in AfAlaDH is not involved in catalysis (steps 1 and 2) [@b0040]. Therefore, it may be reasonable that the V244D (and A228K) mutant of TlLhpI has no significant effect on AlaDH activity ([Tables 1 and 2](#t0005 t0010){ref-type="table"}, and [Fig. 3](#f0015){ref-type="fig"}C), because of the similar mechanism to AfAlaDH, as described above. On the other hand, Glu^56^ of OCD favorably interacts with the δ-amino group of [l]{.smallcaps}-ornithine. In CRYM, it is also proposed that Gly^60^ at the equivalent position (numbering from mouse) is important for the binding of a large ligand, T3, because of the small side chain [@b0140]. These insights explain why the substitution of Leu^52^ in hydrophilic glutamate or arginine in TlLhpI leads to a complete loss of reductive amination activity for hydrophobic 2-oxo acid substrates ([Fig. 3](#f0015){ref-type="fig"}C).

As in our previous proposal [@b0065], dehydratase activity with T3LHyp in the proline racemase superfamily was acquired once at an early evolutional stage, because TlLhpH also forms a single subfamily together with enzymes from bacteria and mammalians ([Fig. S1](#s0115){ref-type="sec"}). Several (thermophilic) archaea and bacteria possess another proline racemase-like gene instead of the *LhpH* gene within the gene cluster containing the *LhpI* gene ([Fig. 1](#f0005){ref-type="fig"}D). The enzymatic function may be interconversion of [l]{.smallcaps}- and [d]{.smallcaps}-isomer of proline (and/or hydroxyproline), but not dehydration of T3LHyp: Pyr2C is potentially produced from [d]{.smallcaps}-proline by FAD-dependent [d]{.smallcaps}-ProDH ([Fig. 1](#f0005){ref-type="fig"}C). TlLhpI (this study; [Fig. 2](#f0010){ref-type="fig"}B) and [l]{.smallcaps}-ProDH (α~4~β~4~) [@b0145] show activities not only for Pyr2C and [l]{.smallcaps}-proline but also Δ^1^-piperidine-2-carboxylate and [l]{.smallcaps}-pipecolate, respectively, which are involved in the so-called "[l]{.smallcaps}-pipecolate pathway" of [d]{.smallcaps}-lysine metabolism [@b0080]. Putative [l]{.smallcaps}-ProDH genes are also found within the gene cluster. Furthermore, (putative) pyruvate-formate lyase (PFL) and serine/threonine dehydratase genes, producing pyruvate and/or 2-oxobutyrate, are often located within the flanking region of the *LhpI* gene ([Fig. 1](#f0005){ref-type="fig"}D). These indicate the possibility that the *TlLhpI* gene (and the gene cluster) is also involved not only in T3LHyp but also in [d]{.smallcaps}-proline, [l]{.smallcaps}-proline and [d]{.smallcaps}-lysine metabolism, and several 2-oxo acids. Although *T. litoralis* can grow on T3LHyp as a sole carbon source, Pyr2C reductase (and T3LHyp dehydratase) activity is not significantly induced in cell-free extract, in contrast of bacteria [@b0065], conforming to the putative functions in multiple metabolism described above. Development of gene disruption of *T. litoralis* would be useful for understanding more detailed physiological role(s) of *TlLhpI* gene.

4. Experimental procedures {#s0050}
==========================

4.1. General procedures {#s0105}
-----------------------

Basic recombinant DNA techniques were performed as described by Sambrook et al. [@b0150]. PCR was carried out using a GeneAmp PCR System 2700 (Applied Biosystems) for 30 cycles in a 50 μl reaction mixture containing 1 U of KOD FX DNA polymerase (TOYOBO), appropriate primers (15 pmol) and template DNA under the following conditions: denaturation at 98 °C for 10 s, annealing at 50 °C for 30 s and extension at 68 °C for the time periods calculated at an extension rate of 1 kbp min^−1^. DNA sequencing was carried out using the BigDye Cycle Sequencing Kit ver.3.1 (Applied Biosystems) and appropriate primers with the Genetic Analyzer 3130 (Applied Biosystems). Protein concentrations were determined by the method of Lowry et al. [@b0155] with bovine serum albumin as the standard. SDS--PAGE was performed as described by Laemmli [@b0160].

4.2. Strain and growth conditions {#s0055}
---------------------------------

*T. litoralis* DSM5473 were grown under anaerobic conditions at 80 °C in a complex medium, as described previously [@b0135], in the absence of sulfur. If necessary, maltose, peptone and yeast extract were omitted, and [l]{.smallcaps}-proline, [d]{.smallcaps}-proline or T3LHyp (30 mM) was added alternatively.

4.3. Plasmid construction for expression of recombinant proteins {#s0060}
----------------------------------------------------------------

Primer sequences used in this study are shown in [Table S1](#s0115){ref-type="sec"}. In this report, the prefixes Tl (*T. litoralis*), Af (*A. fulgidus*), Ab (*A. brasilense*) and Cp (*C. psychrerythraea*) have been added to gene symbols or protein designations when required for clarity. *TlLhpI* (fusion of OCC_00362 and OCC_00367; see [Supplementary Methods](#s0115){ref-type="sec"}) and *TlLhpH* genes (OCC_00387) were amplified by PCR using primers containing appropriate restriction enzyme sites at the 5′ and 3′ ends and genome DNA of *T. litoralis* as a template. Each amplified DNA fragment was introduced into BamHI-PstI sites in pETDuet-1 (Novagen), a plasmid vector for conferring N-terminal His~6~-tag on expressed proteins, to obtain pET/TlLhpI~WT~ and pET/TlLhpH.

4.4. Expression and purification of His~6~-tagged recombinant proteins {#s0065}
----------------------------------------------------------------------

*E. coli* BL21(DE3)-RIL (Novagen) harboring the expression plasmid for His~6~-tagged proteins was grown at 37 °C to a turbidity of 0.6 at 600 nm in Super broth medium (pH 7.0, 12 g tryptone, 24 g yeast extract, 5 ml glycerol, 3.81 g KH~2~PO~4~, and 12.5 g K~2~HPO~4~ per liter) containing 50 mg/liter ampicillin. After the addition of 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside (IPTG), the culture was further grown for 6 h at 37 °C to induce the expression of His~6~-tagged protein. Cells were harvested and resuspended in Buffer A (50 mM sodium phosphate buffer (pH 8.0) containing 300 mM NaCl and 10 mM imidazole). The cells were then disrupted by sonication for 20 min at appropriate intervals on ice using the Ultra Sonic Disruptor Model UR-200P (TOMY SEIKO Co., Ltd., Tokyo, Japan), and the solution was centrifuged at 108,000×*g* for 20 min at 4 °C. The supernatant was loaded onto a Ni--NTA Superflow column (Qiagen) equilibrated with Buffer A linked to the BioAssist eZ system (TOSOH). The column was washed with Buffer B (50 mM sodium phosphate buffer (pH 8.0) containing 300 mM NaCl, 10% (v/v) glycerol, and 50 mM imidazole). The enzymes were then eluted with Buffer C (pH 8.0, Buffer B containing 250 mM imidazole instead of 50 mM imidazole), concentrated by ultrafiltration with Centriplus YM-30 (Millipore), dialyzed against 50 mM Tris--HCl buffer (pH 8.0) containing 50% (v/v) glycerol, and stored at −35 °C until use. If necessary, AbLhpI and CpLhpI proteins were prepared, as described previously [@b0065].

The native molecular mass of recombinant proteins was estimated by gel filtration, which was carried out using HPLC with a Multi-Station LC-8020 model II system (TOSOH) at a flow rate of 1 mL min^−1^. The purified enzyme (∼10 mg mL^−1^) was loaded onto a TSKgel G3000SWXL column (TOSOH) equilibrated with 50 mM Tris--HCl buffer (pH 8.0). A high molecular weight gel filtration calibration kit (GE Healthcare) was used as a molecular marker.

4.5. Enzyme assay {#s0070}
-----------------

All enzyme assays were performed at 50 °C unless otherwise indicated.

Pyr2C reductase was assayed routinely in the direction of Pyr2C reduction by measuring the oxidization of NADH at 340 nm, using a Shimadzu UV-1800 spectrophotometer (Shimadzu GLC Ltd., Tokyo, Japan). The standard assay mixture contained 10 mM Pyr2C in 50 mM potassium phosphate (pH 6.0) buffer. The reactions were started by the addition of 100 μl of a 1.5 mM NADH solution to a final volume of 1 m1. To assay the reverse reaction, the reaction mixture consisted of 50 mM Bis--tris propane (pH 10.5) and 10 mM [l]{.smallcaps}-proline. The reaction was started by the addition of 15 mM NAD^+^ (100 μl) with a final reaction volume of 1 ml. One unit of enzyme activity refers to 1 μmol NADH produced/min. Pyr2C was enzymatically synthesized from T3LHyp, described previously [@b0065].

AlaDH activity was measured as oxidative deamination of [l]{.smallcaps}-alanine and as reductive amination of pyruvate. For the oxidative deamination assay, the standard assay mixture contained 50 mM Bis--tris propane (pH 10.5), 10 mM [l]{.smallcaps}-alanine, and 1.5 mM NAD^+^. The reductive amination assay mixture consisted of 50 mM Tris--HCl (pH 8.0), 700 mM NH~4~Cl, 10 mM pyruvate, and 0.15 mM NADH. For the assay of NMAlaDH activity, 50 mM methylamine was used instead of 700 mM NH~4~Cl.

T3LHyp dehydratase was assayed spectrophotometrically in the coupling system with TlLhpI. The reaction mixture consisted of 50 mM Tris--HCl (pH 8.0), 0.15 mM NADH, and 10 μg purified TlLhpI. The reaction was started by the addition of 100 mM T3LHyp (100 μl) with a final reaction volume of 1 ml. The enzyme was alternatively assayed by the colorimetric method based on the reaction of 2-aminobenzaldehyde with Pyr2C, which yields a yellow reaction product [@b0075]. This method was used to determine the optimum temperature for activity.

4.6. Reaction product analysis {#s0075}
------------------------------

Purified TlLhpI (10 μg) was added to the following four mixtures (1 ml): for AlaDH activity, 50 mM Tris--HCl (pH 8.0) buffer containing 10 mM pyruvate (or 2-oxobutyrate), 500 mM NH~4~Cl, and 10 mM NADH; for NMAlaDH activity, 50 mM Tris--HCl (pH 8.0) buffer containing 10 mM pyruvate, 100 mM methylamine, and 10 mM NADH; for [l]{.smallcaps}-ProDH activity; 50 mM Bis--tris propane (pH 10.5) buffer containing 10 mM [l]{.smallcaps}-proline and 10 mM NAD^+^; for T3LHyp dehydratase activity of TlLhpH; 50 mM Tris--HCl (pH 8.0) buffer containing 10 mM T3LHyp, 10 mM NADH, and TlLhpH (10 μg). After incubation at 50 °C overnight, each enzyme product was then analyzed by a Hitachi L-8900 amino acid analyzer (Tokyo, Japan), using ion exchange chromatography followed by post-column derivatization with ninhydrin. In the case of [l]{.smallcaps}-ProDH activity, the product was further oxidized by the addition of 30% H~2~O~2~ (20 μl) to the mixture before HPLC analysis [@b0165].

4.7. Zymogram staining analysis {#s0080}
-------------------------------

Purified TlLhpI was separated at 4 °C on non-denaturing PAGE with 10% (w/v) gel, which was performed by omitting SDS and 2-mercaptoethanol from the solution used in SDS--PAGE. The gels were then soaked in 10 ml staining solution consisting of 50 mM Bis--tris propane (pH 10), 0.25 mM nitroblue tetrazolium (NBT), 0.06 mM phenazine methosulfate (PMS), 10 mM substrate, and 10 mM NAD^+^ at 50 °C for 5 min in the dark. Dehydrogenase activity appeared as a dark blue band.

4.8. Site-directed mutagenesis {#s0085}
------------------------------

The mutation in TlLhpI was introduced by sequential steps of PCR [@b0170] using sense and antisense primers ([Table S1](#s0115){ref-type="sec"}) and pET/TlLhpI~WT~ (for V224D/A228K (DK) mutant) or pET/TlLhpI~DK~ (for L52E/V224D/A228K (EDK) and L52R/V224D/A228K (RDK) mutants) as a template. Briefly, the codons used for single mutants were as follows: L52E, CTG → AGG; L52R, CTG → GAG; V224D, GTG → GAC; A228K, GCC → AAG. The coding region of the mutated genes was confirmed by subsequent sequencing in both directions. Mutant proteins were expressed and purified by the same procedures as for the wild-type enzyme.

4.9. Amino acid sequence alignment and phylogenetic analysis {#s0090}
------------------------------------------------------------

Protein sequences were analyzed using the Protein-BLAST and Clustal W program distributed by DDBJ (DNA Data Bank of Japan) ([www.ddbj.nig.ac.jp](http://www.ddbj.nig.ac.jp){#ir0015}). Multiple sequence alignment was performed with the following default parameters: Protein Weight Matrix, Gonnet; GAP OPEN, 10; GAP EXTENSION, 0.20; GAP DISTANCES, 5; NO END GAPS, no; ITERATION, none; NUMITER, 1 and CLUSTERING, NJ. The phylogenetic tree was constructed by the neighbor-joining method [@b0175]. Bootstrap resampling was performed 1000 times.

Appendix A. Supplementary data {#s0115}
==============================

Supplementary data 1Supplementary Fig. S1Primers used in this study.Supplementary Fig. S2Phylogenetic analysis of TlLhpH.Supplementary Table S1Temperature dependence of Pyr2C reductase and T3LHyp dehydratase activities.
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![(A) Pathways of [l]{.smallcaps}-proline biosynthesis. (B) Proposed hydrolytic (Scheme I) and non-hydrolytic schemes (Scheme II) for the conversion of [l]{.smallcaps}-ornithine to [l]{.smallcaps}-proline by OCD [@b0045]. Step 6 corresponds to the reaction by Pyr2C reductase. *Asterisks* indicate putative intermediates. (C) T3LHyp pathway and the metabolic network with [d]{.smallcaps}-proline. (D) Schematic gene clusters related to T3LHyp and/or proline metabolism of archaea (*A*) and bacteria (*B*). Putative genes in the box were purified and characterized in this study (see (E)). *TlLhpI* gene was fused with OCC_00362 and OCC_00367 genes (Supplementary Methods). *C*--*C* and *C--T* indicate a pair of catalytic amino acid residues of proline racemase superfamily enzymes (see [Fig. S1B](#s0115){ref-type="sec"}). *Gray* putative genes are sequentially similar to other (amino acid) transporters. (E) Purification of recombinant His~6~ tag proteins. Five micrograms each of purified protein were applied to 12% (w/v) gel (also (F)). (F) Purification of recombinant His~6~ tag TlLhpI mutants.](gr1){#f0005}

![Enzymatic properties of TlLhpI Pyr2C. (A) Effect of pH on the activity as AlaDH *left panel*) and Pyr2C reductase (*right panel*). 50 mM acetate-NaOH (pH 4.0--6.0) (*square*), 50 mM potassium phosphate (pH 6.0--8.5) (*circle*), 50 mM Tris--HCl (pH 7.0--9.0) (*triangle*) for the reduction of pyruvate or Pyr2C (*left axis* and *black symbol*), and 50 mM Bis--tris propane (*diamond*) for the oxidization of [l]{.smallcaps}-alanine or [l]{.smallcaps}-proline (*right axis* and *gray symbol*), instead of 50 mM buffer under each standard assay condition. (B) Zymogram staining. Five micrograms each of purified protein was applied on 10% (w/v) gel. After electrophoresis, the gel was soaked at 50 °C (for TlLhpI) or 30 °C (for AbLhpI) in staining solution in the presence of the indicated substrate and NAD^+^ (each of 10 mM). Protein stained with Coomassie Brilliant Blue (*CBB*) was used as a loading control. (C) Comparison of NADH-dependent AlaDH and Pyr2C reductase activities of wild-type and mutated TlLhpI proteins. The assay was performed with standard assay solution containing the indicated substrate (10 mM). AbLhpI and CpLhpI were assayed at 30 °C under the standard assay conditions for TlLhpI. Data for AfAlaDH are from Ref. [@b0035].](gr2){#f0010}

![HPLC analysis of the reaction products. (A) Reaction product from pyruvate or 2-oxobutyrate by TlLhpI (as AlaDH) in presence of NADH and NH~4~Cl. *Control* indicates authentic [l]{.smallcaps}-alanine and [l]{.smallcaps}-2-aminobutyrate. (B) Reaction product from pyruvate by TlLhpI (as NMAlaDH) in the presence of NADH and methylamine. *Control* indicates authentic *N*-methyl-[l]{.smallcaps}-alanine. (C) Reaction product from [l]{.smallcaps}-proline by TlLhpI (as [l]{.smallcaps}-ProDH) in the presence of NAD^+^. After the enzymatic reaction, the product was treated by H~2~O~2~, and then analyzed. *Control* indicates authentic [l]{.smallcaps}-glutamate and γ-aminobutyrate (GABA), which are potentially yielded from Pyr5C and Pyr2C, respectively. (D) Reaction products from Pyr2C by TlLhpI and from T3LHyp by TlLhpH and TlLhpI, in the presence of NADH. *Control* indicates authentic T3LHyp and [l]{.smallcaps}-proline. No peak corresponding to Pyr2C was observed, probably caused by no reaction with labeling reagent for amino acid analysis (data not shown).](gr3){#f0015}

![Phylogenetic tree of OCD/CRYM protein superfamily consisting of eleven subfamilies. The number on each branch indicates the bootstrap value. Proteins with asterisks were used for [Fig. 5](#f0025){ref-type="fig"}A.](gr4){#f0020}

![(A) Partial multiple sequence alignment of deduced amino acid sequences of TlLhpI. Binding sites for a carboxyl group of substrate are shaded in *violet*, *green*, *yellow* and *light-green*. Aspartate, lysine and glutamate residues, related to the cyclization by OCD, are shaded in *blue*, *orange*, and *red*, respectively. A specific aspartate residue for NAD^+^(H)-dependent enzymes, potentially interacting with 2′- and 3′-hydroxyl groups in the ribosyl moiety of NAD^+^(H), are shaded in *pink*. Amino acid residues Coenzyme-binding motif of Rossmann-fold are shown as *white letters in black boxes*. *Gray-shaded letters* indicate highly conserved amino acid residues. (B) Schematic diagram showing the interactions of [l]{.smallcaps}-ornithine (*left panel*) and [l]{.smallcaps}-alanine (*right panel*), and nearby residues in OCD and AlaDH, respectively. Color of residues correspond to [Fig. 5](#f0025){ref-type="fig"}A. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr5){#f0025}

###### 

Kinetic parameters of NAD^+^-dependent oxidation reaction.

  Enzymes                              Substrates                                                         Specific activity[a](#tblfn1){ref-type="table-fn"} (units/mg protein)   *K*~m~ (mM)                                                 *k*~cat~ (min^−1^)                                            *k*~cat~/*K*~m~ (min^−1^ mM^−1^)
  ------------------------------------ ------------------------------------------------------------------ ----------------------------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------- ----------------------------------
  Wild type                            [l]{.smallcaps}-Alanine                                            0.0265 ± 0.0015                                                         18.2 ± 5.0                                                  2.64 ± 0.55                                                   0.147 ± 0.012
  [l]{.smallcaps}-2-Aminobutyrate      0.136 ± 0.010                                                      6.00 ± 0.29                                                             6.71 ± 0.16                                                 1.12 ± 0.03                                                   
  [l]{.smallcaps}-2-Aminovalerate      0.396 ± 0.030                                                      0.306 ± 0.009                                                           6.56 ± 0.08                                                 21.5 ± 0.4                                                    
  [l]{.smallcaps}-Leucine              0.248 ± 0.010                                                      1.32 ± 0.10                                                             10.5 ± 0.4                                                  8.00 ± 0.28                                                   
  *N*-Methyl-[l]{.smallcaps}-alanine   0.526 ± 0.025                                                      0.406 ± 0.044                                                           11.6 ± 0.7                                                  28.6 ± 2.1                                                    
  [l]{.smallcaps}-Proline              0.384 ± 0.015 (0.0376 ± 0.0005)[b](#tblfn2){ref-type="table-fn"}   1.12 ± 0.12 (13.1 ± 1.2)[b](#tblfn2){ref-type="table-fn"}               13.8 ± 1.0 (3.27 ± 0.24)[b](#tblfn2){ref-type="table-fn"}   12.3 ± 0.4 (0.250 ± 0.006)[b](#tblfn2){ref-type="table-fn"}   
  [l]{.smallcaps}-Pipecolate           0.219 ± 0.020                                                      0.608 ± 0.115                                                           12.2 ± 1.3                                                  20.3 ± 1.8                                                    
                                                                                                                                                                                                                                                                                                            
  V224D/A228K                          [l]{.smallcaps}-Alanine                                            0.0133 ± 0.0010                                                         36.9 ± 0.9                                                  2.12 ± 0.02                                                   0.0575 ± 0.0008
  [l]{.smallcaps}-2-Aminovalerate      0.666 ± 0.050                                                      2.13 ± 0.30                                                             7.72 ± 0.82                                                 3.64 ± 0.12                                                   
  [l]{.smallcaps}-Proline              1.51 ± 0.10                                                        0.444 ± 0.008                                                           36.5 ± 0.9                                                  82.2 ± 1.1                                                    

Under standard assay conditions in "Experimental procedures". All substrate concentrations were 10 mM.

NADP^+^-dependent activity.

###### 

Kinetic parameters of NADH-dependent reductive reaction.

  Enzymes                                                      Substrates    Specific activity[a](#tblfn3){ref-type="table-fn"} (units/mg protein)   *K*~m~ (mM)    *k*~cat~ (min^−1^)   *k*~cat~/*K*~m~ (min^−1^ mM^−1^)
  ------------------------------------------------------------ ------------- ----------------------------------------------------------------------- -------------- -------------------- ----------------------------------
  Wild type                                                    Pyruvate      4.43 ± 0.50                                                             9.37 ± 0.23    315 ± 4              33.6 ± 0.4
  Oxalacetate                                                  1.78 ± 0.18   8.86 ± 0.91                                                             192 ± 15       21.7 ± 0.5           
  2-Oxobutyrate                                                2.46 ± 0.25   0.701 ± 0.020                                                           92.0 ± 1.8     131 ± 1              
  2-Oxovalerate                                                2.59 ± 0.21   0.969 ± 0.093                                                           152 ± 11       157 ± 3              
  4-Methyl-2-oxovalerate                                       1.02 ± 0.19   2.52 ± 0.45                                                             129 ± 18       51.4 ± 2.0           
  NH~4~^+^ (+2-oxovalerate)[b](#tblfn4){ref-type="table-fn"}   2.45 ± 0.22   1450 ± 240                                                              267 ± 33       0.183 ± 0.007        
  Pyr2C                                                        23.9 ± 2.5    0.944 ± 0.090                                                           995 ± 33       1058 ± 66            
                                                                                                                                                                                         
  V224D/A228K                                                  Pyruvate      1.60 ± 0.15                                                             62.0 ± 12.2    413 ± 75             6.68 ± 0.11
  2-Oxovalerate                                                7.00 ± 0.95   1.82 ± 0.14                                                             212 ± 16       116 ± 0              
  Pyr2C                                                        239 ± 35      2.77 ± 0.44                                                             33500 ± 4900   12900 ± 300          

Under standard assay conditions in "Experimental procedures". All substrate concentrations were 10 mM.

The NH~4~^+^ concentrations were changed with a fixed concentration of 2-oxovalerate (10 mM).
